Quarterly ResultAug 10, 2026, 05:27 PM
Mesa Labs Q1 Revenue $60.1M, Net Income $2.8M; Operating Income Up 129%
AI Summary
Mesa Laboratories reported Q1 2026 revenue of $60.1 million, a modest increase from the prior year. Despite a significant rise in operating income to $7.0 million, net income and diluted EPS saw substantial declines, reaching $2.8 million and $0.49 respectively. The company also reduced its revolving line of credit balance and settled a previously disclosed litigation.
Key Highlights
- Revenue increased by 1.0% year-over-year to $60.1 million for Q1 2026.
- Net income decreased by 40.3% to $2.8 million for the quarter.
- Diluted earnings per share (EPS) was $0.49, down from $0.85 in Q1 2025.
- Operating income surged by 129.5% to $7.0 million for the quarter.
- Net cash provided by operating activities was $14.7 million, up from $1.9 million.
- Biopharmaceutical Development segment revenue grew 5.0% to $12.1 million.
- Calibration Solutions segment revenue increased 7.6% to $13.3 million.
- Revolving line of credit balance reduced by $7.25 million to $77.25 million.
Price Impact
More from MLAB